Optogenetic Control of Oncogenic Signaling in B-Cell Malignancies

被引：0
|
作者：
Kume, Kohei [1 ]
Lee, Jaewoong [1 ,2 ]
Cheng, Zhangliang [1 ]
Robinson, Mark E. [1 ]
Leveille, Etienne [1 ]
Cosgun, Kadriye Nehir [1 ]
Chan, Lai N. [1 ]
Feng, Yanzhi [1 ]
Fonseca, David [1 ]
Khanduja, Dhruv [1 ]
Toomre, Derek [3 ]
Muschen, Markus [1 ]
机构：
[1] Yale Univ, Ctr Mol & Cellular Oncol, New Haven, CT USA
[2] Korea Univ, Sch Biosyst & Biomed Sci, Seoul, South Korea
[3] Yale Univ, Dept Cell Biol & Biophys, New Haven, CT USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190926
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] B-CELL MALIGNANCIES FREQUENTLY TARGET THE AUTOREACTIVE B-CELL REPERTOIRE
    DIGHIERO, G
    BORCHE, L
    LEUKEMIA & LYMPHOMA, 1991, 5 : 47 - 51
  • [32] The development of BCR signaling pathway-targeted therapy for B-cell malignancies
    Munakata, Wataru
    ANNALS OF ONCOLOGY, 2022, 33 : S431 - S431
  • [33] Oncogenic Mutational Disruption of KLHL6 Dimers Fuels B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma
    Meriranta, Leo
    Sorri, Selma
    Zafar, Sadia
    Liu, Xiaonan
    Sahlberg, Eerika
    Dufva, Olli
    Goos, Helka
    Karjalainen-Lindsberg, Marja-Liisa
    Varjosalo, Markku
    Hyytiainen, Marko
    Leppa, Sirpa
    BLOOD, 2022, 140 : 5889 - 5890
  • [34] Dynamic Assembly of a Feedback Complex to Regulate Oncogenic B-Cell Receptor-Signaling
    Lee, Jaewoong
    Kume, Kohei
    Chen, Zhengshan
    Xiao, Gang
    Cosgun, Kadriye Nehir Nehir
    Chen, Liting
    Chan, Lai N.
    Klemm, Lars
    Chen, Chun-Wei David
    Ma, Ning
    Chan, Wing C.
    Forman, Stephen J.
    Zammarchi, Francesca
    Van Berkel, Patrick
    Melnick, Ari
    Ngo, Vu N.
    Geng, Huimin
    Luger, Selina M.
    Litzow, Mark
    McManus, Michael T.
    Vaidehi, Nagarajan
    Paietta, Elisabeth M.
    Meffre, Eric
    Weinstock, David M.
    Muschen, Markus
    BLOOD, 2019, 134
  • [35] Somatic hypermutation and B-cell malignancies
    Spencer, J
    Dunn-Walters, DK
    JOURNAL OF PATHOLOGY, 1999, 187 (02): : 158 - 163
  • [36] Lenalidomide for the treatment of B-cell malignancies
    Chanan-Khan, Asher A.
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1544 - 1552
  • [37] Genomic Heterogeneity in B-Cell Malignancies
    Friedman, Daphne R.
    Nevins, Joseph R.
    BLOOD, 2011, 118 (21) : 1480 - 1480
  • [38] SUMMARY OF THE SYMPOSIUM ON B-CELL MALIGNANCIES
    SHIMOYAMA, M
    TAKATSUKI, K
    KOJIMA, M
    SUEMASU, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1983, 13 (03) : 633 - 634
  • [39] Idelalisib for treatment of B-cell malignancies
    Do, Bryan
    Mace, Morgan
    Rexwinkle, Amber
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (08) : 547 - 555
  • [40] Proteomic analysis of B-cell malignancies
    Boyd, Robert S.
    Dyer, Martin J. S.
    Cain, Kelvin
    JOURNAL OF PROTEOMICS, 2010, 73 (10) : 1804 - 1822
12345